Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Gamel

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Cancer|February 1, 1988
Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excisionJ W Gamel, I W McLean, R A Greenberg
Computers and Biomedical Research, an International Journal|February 1, 1988
A stable linear algorithm for fitting the lognormal model to survival dataJ W Gamel, R A Greenberg, I W McLean
British Journal of Cancer|July 1, 1993
Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinomaJ W Gamel, R L Vogel, I W McLean
Cancer|September 15, 1995
Proliferative rate by S-phase measurement may affect cure of breast carcinomaJ W Gamel, J S Meyer, M A Province
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in miceG E Sanborn, J Y Niederkorn, J W Gamel
Analytical and Quantitative Cytology and Histology|September 1, 1985
Reproducibility of nucleolar measurements in human intraocular melanoma cells on standard histologic microslidesJ W Gamel, J Gleason, H Williams, et al.
Investigative Ophthalmology & Visual Science|May 1, 1992
A comparison of prognostic covariates for uveal melanomaJ W Gamel, J B McCurdy, I W McLean
Investigative Ophthalmology & Visual Science|November 1, 1987
Suicide enzyme inhibition as a chemotherapeutic strategy for controlling metastases derived from intraocular melanomasJ Y Niederkorn, G E Sanborn, J W Gamel
Cancer|April 1, 1993
Biologic distinctions between cure and time to death in 2892 patients with intraocular melanomaJ W Gamel, I W McLean, J B McCurdy
Cancer|August 25, 1991
Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolaseM N Burnier, I W McLean, J W Gamel
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cancer|February 1, 1988
Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excisionJ W Gamel, I W McLean, R A Greenberg
Computers and Biomedical Research, an International Journal|February 1, 1988
A stable linear algorithm for fitting the lognormal model to survival dataJ W Gamel, R A Greenberg, I W McLean
British Journal of Cancer|July 1, 1993
Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinomaJ W Gamel, R L Vogel, I W McLean
Cancer|September 15, 1995
Proliferative rate by S-phase measurement may affect cure of breast carcinomaJ W Gamel, J S Meyer, M A Province
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Efficacy of dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in miceG E Sanborn, J Y Niederkorn, J W Gamel
Analytical and Quantitative Cytology and Histology|September 1, 1985
Reproducibility of nucleolar measurements in human intraocular melanoma cells on standard histologic microslidesJ W Gamel, J Gleason, H Williams, et al.
Investigative Ophthalmology & Visual Science|May 1, 1992
A comparison of prognostic covariates for uveal melanomaJ W Gamel, J B McCurdy, I W McLean
Investigative Ophthalmology & Visual Science|November 1, 1987
Suicide enzyme inhibition as a chemotherapeutic strategy for controlling metastases derived from intraocular melanomasJ Y Niederkorn, G E Sanborn, J W Gamel
Cancer|April 1, 1993
Biologic distinctions between cure and time to death in 2892 patients with intraocular melanomaJ W Gamel, I W McLean, J B McCurdy
Cancer|August 25, 1991
Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolaseM N Burnier, I W McLean, J W Gamel
Pageof 8